| Product NDC: | 64980-149 | 
| Proprietary Name: | Probenecid and Colchicine | 
| Non Proprietary Name: | Probenecid and Colchicine | 
| Active Ingredient(s): | .5; 500 mg/1; mg/1 & nbsp; Probenecid and Colchicine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 64980-149 | 
| Labeler Name: | Rising Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA040618 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080513 | 
| Package NDC: | 64980-149-10 | 
| Package Description: | 1000 TABLET in 1 BOTTLE (64980-149-10) | 
| NDC Code | 64980-149-10 | 
| Proprietary Name | Probenecid and Colchicine | 
| Package Description | 1000 TABLET in 1 BOTTLE (64980-149-10) | 
| Product NDC | 64980-149 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Probenecid and Colchicine | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20080513 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Rising Pharmaceuticals, Inc. | 
| Substance Name | COLCHICINE; PROBENECID | 
| Strength Number | .5; 500 | 
| Strength Unit | mg/1; mg/1 | 
| Pharmaceutical Classes | Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Interactions [MoA] |